Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
Abstract Background Stereotactic Body Radiotherapy (SBRT) has shown effectiveness in treating bone metastases to alleviate pain. The benefit of SBRT may be further harnessed especially when radiating disease from primary malignancies with low alpha–beta ratios in order to maximize the magnitude and...
Main Authors: | Eric K. Nguyen, Kimmen Quan, Sameer Parpia, Stephan Tran, Anand Swaminath |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-021-01897-0 |
Similar Items
-
Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer
by: Adam Mutsaers, et al.
Published: (2017-06-01) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
by: Kang Liang Zeng, et al.
Published: (2019-05-01) -
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01) -
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
by: Laila König, et al.
Published: (2020-02-01) -
Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
by: Loi M, et al.
Published: (2019-11-01)